Toggle light / dark theme

Rethinking CAR T: modular manufacturing versus allinone systems

As demand for CAR T therapies grows, modular platforms are offering process development teams new ways to improve cell expansion, recovery and scale-up.

Leave a Comment

Lifeboat Foundation respects your privacy! Your email address will not be published.

/* */